Data / Form D filings / Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc.: Form D filings
Aclaris Therapeutics, Inc., a pharmaceuticals company in Wayne, PA, filed 8 Form D notices with the SEC between 2012 and 2024. The latest, on December 4, 2024, reports $80 million sold of a $80 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 701 LEE ROAD, SUITE 103, Wayne, PA, 19087
- Phone
- (484) 324-7933
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1557746
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 4, 2024 | New notice | $79,999,999 | $79,999,999 | 19 | Nov 19, 2024 | sec.gov | |
| Apr 8, 2020 | New notice | $11,440,000 | $11,000,000 | $440,000 | 1 | Mar 30, 2020 | sec.gov |
| Aug 13, 2018 | Amendment | $12,500,000 | $10,000,000 | $2,500,000 | 41 | Aug 3, 2017 | sec.gov |
| Aug 14, 2017 | New notice | $12,500,000 | $10,000,000 | $2,500,000 | 42 | Aug 3, 2017 | sec.gov |
| Jun 14, 2016 | New notice | $20,000,017 | $20,000,017 | 9 | Jun 2, 2016 | sec.gov | |
| Sep 11, 2015 | New notice | $40,000,000 | $40,000,000 | 28 | Aug 28, 2015 | sec.gov | |
| Oct 8, 2014 | New notice | $21,288,488 | $10,644,244 | $10,644,244 | 25 | Sep 30, 2014 | sec.gov |
| Sep 10, 2012 | New notice | $20,890,000 | $20,890,000 | 31 | Aug 30, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Schiff | Director | |
| Joseph Monahan | Executive Officer | |
| Anand Mehra | Director | |
| Hugh Davis | Executive Officer, Director | |
| James Loerop | Executive Officer | |
| Neal Walker | Executive Officer, Director | |
| Vincent Milano | Director | |
| William Humphries | Director | |
| Kevin Balthaser | Executive Officer | |
| Christopher Molineaux | Director | |
| Maxine Gowen | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Dec 2, 2024 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aclaris Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.